These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 32114594

  • 1. Immunohistochemistry of mammary Paget's disease. Cytokeratin 7, GATA3, and HER2 are sensitive markers.
    Arain SA, Arafah M, Said Raddaoui EM, Tulba A, Alkhawaja FH, Al Shedoukhy A.
    Saudi Med J; 2020 Mar; 41(3):232-237. PubMed ID: 32114594
    [Abstract] [Full Text] [Related]

  • 2. Molecular subtyping of mammary Paget's disease using immunohistochemistry.
    Arafah M, Arain SA, Raddaoui EMS, Tulba A, Alkhawaja FH, Al Shedoukhy A.
    Saudi Med J; 2019 May; 40(5):440-446. PubMed ID: 31056619
    [Abstract] [Full Text] [Related]

  • 3. Not All Cases of Mammary Paget's Disease are Cytokeratin-7 Positive: A Challenging Diagnosis!
    Anja K, Hélène D, Pascal VE, Liliane M, Mieke VB.
    Int J Surg Pathol; 2021 Sep; 29(6):631-634. PubMed ID: 33750236
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Different panels of markers should be used to predict mammary Paget's disease associated with in situ or invasive ductal carcinoma of the breast.
    Lester T, Wang J, Bourne P, Yang Q, Fu L, Tang P.
    Ann Clin Lab Sci; 2009 Sep; 39(1):17-24. PubMed ID: 19201736
    [Abstract] [Full Text] [Related]

  • 7. Transcriptome analyses reveal FOXA1 dysregulation in mammary and extramammary Paget's disease.
    Mai R, Zhou S, Zhou S, Zhong W, Hong L, Wang Y, Lu S, Pan J, Huang Y, Su M, Crawford R, Zhou Y, Zhang G.
    Hum Pathol; 2018 Jul; 77():152-158. PubMed ID: 29630912
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Apocrine gland carcinoma of the mammary skin concomitant with pagetoid phenomenon.
    Usui K, Ochiai T, Abe I, Nishio H, Togo K, Yamagata M.
    J Dermatol; 2010 Apr; 37(4):350-4. PubMed ID: 20507405
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cytokeratin 7-negative and GATA binding protein 3-negative breast cancers: Clinicopathological features and prognostic significance.
    Lu S, Yakirevich E, Wang LJ, Resnick MB, Wang Y.
    BMC Cancer; 2019 Nov 12; 19(1):1085. PubMed ID: 31718619
    [Abstract] [Full Text] [Related]

  • 19. Paget's disease of the nipple in a Her2-positive breast cancer xenograft model.
    Drews-Elger K, Sandoval-Leon AC, Ergonul AB, Jegg AM, Gomez-Fernandez C, Miller PC, El-Ashry D, Lippman ME.
    Breast Cancer Res Treat; 2020 Feb 12; 179(3):577-584. PubMed ID: 31720992
    [Abstract] [Full Text] [Related]

  • 20. Characterisation of GATA3 expression in invasive breast cancer: differences in histological subtypes and immunohistochemically defined molecular subtypes.
    Shaoxian T, Baohua Y, Xiaoli X, Yufan C, Xiaoyu T, Hongfen L, Rui B, Xiangjie S, Ruohong S, Wentao Y.
    J Clin Pathol; 2017 Nov 12; 70(11):926-934. PubMed ID: 28428285
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.